SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (2): 203-208.doi: 10.3736/jcim20080220

• Literature Review • Previous Articles     Next Articles

Progress of integrative medicine, human papillomavirus vaccine and molecular targeted therapy for cervical cancer

Chi-shing Cho()   

  1. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
  • Received:2007-08-17 Online:2008-02-20 Published:2008-02-15
  • Contact: CHO Chi-shing E-mail:chocs@ha.org.hk

RichHTML

1

PDF (PC)

57

Like

0

Key words: cervical cancer, human papillomavirus, vaccines, diagnosis, therapy, integrated Chinese traditional and Western medicine therapy

CLC Number: 

  • R737.3
[1] Feeley C . Advances in cervical cancer screening and human papillomavirus vaccines. J Br Menopause Soc. 2006; 12(1):19-23.
doi: 10.1258/136218006775997252 pmid: 16513018
[2] Parkin DM, Bray F, Ferlay J , et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108.
[3] Doorbar J . Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110(5):525-541.
doi: 10.1042/CS20050369
[4] Martin CM, Astbury K , O'Leary JJ. Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn. 2006 ; 6(2):217-229.
doi: 10.1586/14737159.6.2.217 pmid: 16512781
[5] Haverkos HW . Multifactorial etiology of cervical cancer: a hypothesis. MedGenMed. 2005; 7(4) : 57.
pmid: 16614679
[6] Danaei G, Vander Hoorn S, Lopez AD , et al. Causes of cancer in the world : comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005; 366(9499):1784-1793.
doi: 10.1016/S0140-6736(05)67725-2
[7] International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors : Collaborative reanalysis of individual data on 16, 563 women with cervical carcinoma and 33, 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006; 119(5):1108-1124.
[8] Rieck G, Fiander A . The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol. 2006; 20(2):227-251.
doi: 10.1016/j.bpobgyn.2005.10.010 pmid: 16543119
[9] Valdespino VM, Valdespino VE . Cervical cancer screening : state of the art. Curr Opin Obstet Gynecol. 2006; 18(1):35-40.
doi: 10.1097/01.gco.0000192971.59943.89 pmid: 16493258
[10] Zeferino LC, Derchain SF . Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol. 2006; 20(3):339-354.
doi: 10.1016/j.bpobgyn.2006.01.018 pmid: 11577044
[11] Calloway C, Jorgensen CM, Saraiya M , et al. A content analysis of news coverage of the HPV vaccine by U. S. newspapers,January 2002-June 2005. J Womens Health (Larchmt). 2006; 15(7):803-809.
doi: 10.1089/jwh.2006.15.803
[12] Ljubojevic S . The human papillomavirus vaccines. Acta Dermatovenerol Croat. 2006; 14(3):208.
[13] Hanna E, Bachmann G . HPV vaccination with Garda- sil : a breakthrough in womens health. Expert Opin Biol Ther. 2006; 6(11):1223-1227.
doi: 10.1517/14712598.6.11.1223
[14] McLemore MR . Gardasil: Introducing the new human papillomavirus vaccine. Clin J Oncol Nurs. 2006; 10(5):559-560.
doi: 10.1188/06.CJON.559-560 pmid: 17063609
[15] HPV vaccine fights cervical cancer. CA Cancer J Clin. 2006; 56(5):249-250.
[16] Prandi S, Beccati D, De Aloysio G , et al. Applicability of the Bethesda System 2001 to a public health setting. Cancer. 2006; 108(5):271-276.
doi: 10.1002/cncr.22167 pmid: 16948127
[17] Long HJ 3rd, Laack NN, Gostout BS . Prevention, diagnosis ,and treatment of cervical cancer. Mayo Clin Proc. 2007; 82(12):1566-1574.
doi: 10.1016/S0025-6196(11)61104-X pmid: 18053467
[18] Kalliala I, Nieminen P, Dyba T , et al. Cancer free survival after CIN treatment: comparisons of treatment methods and histology. Gynecol Oncol. 2007; 105(1):228-233.
doi: 10.1016/j.ygyno.2006.12.028 pmid: 17289128
[19] Canis M, Farina M, Jardon K , et al. Laparoscopy and gynecologic cancer in 2005. J Gynecol Obstet Biol Reprod (Paris). 2006; 35(2):117-135.
doi: 10.1016/S0368-2315(06)76386-4
[20] Cuzick J, Clavel C, Petry KU , et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119(5):1095-1101.
[21] McCaffery K, Waller J, Nazroo J , et al. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006; 82(2):169-174.
doi: 10.1136/sti.2005.016436 pmid: 16581749
[22] Zheng Y, Peng ZL, Lou JY , et al. Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction. Ai Zheng. 2006; 25(3):373-377. Chinese with abstract in English.
doi: 10.3321/j.issn:1000-467X.2006.03.024
郑莹, 彭芝兰, 楼江燕 , 等. 多重实时PCR对宫颈癌组织及SiHa细胞株HPV-16病毒存在状态的检测.癌症. 2006; 25(3):373-377.
doi: 10.3321/j.issn:1000-467X.2006.03.024
[23] Dimopoulos JC, Schard G, Berger D , et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys. 2006; 64(5):1380-1388.
[24] Chung HH, Kim SK, Kim TH , et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis. Gynecol Oncol. 2006; 103(1):165-170.
doi: 10.1016/j.ygyno.2006.02.016
[25] Falkenberg E, Kim RY, Meleth S , et al. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Brachytherapy. 2006 ; 5(1):49-55.
doi: 10.1016/j.brachy.2005.12.001
[26] Gerszten K, Colonello K, Heron DE , et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol. 2006; 102(2):182-188.
doi: 10.1016/j.ygyno.2005.12.044
[27] Nakano T, Suzuki Y, Ohno T , et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res. 2006; 12(7 parti):2185-2190.
doi: 10.1158/1078-0432.CCR-05-1907
[28] Lee KH, Yim EK, Kim CJ , et al. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005; 98(1) : 45-53.
doi: 10.1016/j.ygyno.2005.04.010 pmid: 15907983
[29] Ohno T, Kato S, Wakatsuki M , et al. Incidence and temporal pattern of anorexia,diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: Comparison with radiation therapy alone. Gynecol Oncol. 2006; 103(1):94-99.
doi: 10.1016/j.ygyno.2006.01.048
[30] Potter R, Dimopoulos J, Bachtiary B , et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol. 2006; 79(1):80-86.
doi: 10.1016/j.radonc.2006.01.007
[31] Tanaka T, Bai T, Yukawa K , et al. Optimal combination chemotherapy and chemoradiotherapy with etopo- side for advanced cervical squamous cancer cells in vitro. Oncol Rep. 2006; 15(4):939-947.
[32] Wong YF, Selvanayagam ZE, Wei N , et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res. 2003; 9(15):5486-5492.
[33] Zhang Z, Huettner PC, Nguyen L , et al. Aberrant promoter methylation and silencing of the FOU2F3 gene in cervical cancer. Oncogene. 2006; 25(39) : 5436-5445.
doi: 10.1038/sj.onc.1209530 pmid: 16607278
[34] Huang FY, Chiu PM, Tam KF , et al. Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol Oncol. 2006; 103(1):219-225.
doi: 10.1016/j.ygyno.2006.02.028
[35] Ueda M, Terai Y, Kanda K , et al. Fas gene promoter- 670 polymorphism in gynecological cancer. Int J Gynecol Cancer. 2006; 16 Suppl 1: 179-182.
doi: 10.1111/j.1525-1438.2006.00505.x pmid: 16515587
[36] Yim EK, Park JS . Role of proteomics in translational research in cervical cancer. Expert Rev Proteomics. 2006; 3(1):21-36.
doi: 10.1586/14789450.3.1.21 pmid: 16445348
[37] Feng YH, Li X , Wang et al. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem. 2006; 281(25):17228-17237.
doi: 10.1074/jbc.M602999200
[38] Bae SM, Lee CH, Cho YL , et al. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol. 2005; 99(1):26-35.
doi: 10.1016/j.ygyno.2005.05.041 pmid: 16051329
[39] Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S , et al. Cyclin Al promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer. 2006; 6:55.
doi: 10.1186/1471-2407-6-55 pmid: 1435765
[40] Zhao M, Kim YT, Yoon BS , et al. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol. 2006; 28(1):44-48.
doi: 10.1016/S0168-8278(01)00079-4 pmid: 16614707
[41] Li HY, Xu Q, Zhu T, et al. Expression and clinical significance of Pinl and Cyclin D1 in cervical cancer cell lines and cervical epithelial tissues. Ai Zheng. 2006; 25(3):367-372. Chinese with abstract in Engliah.
doi: 10.3969/j.issn.1000-467X.2006.03.023
李红雨, 徐茜, 朱涛 , 等. 宫颈癌细胞株和宫颈上皮组织中Pinl和Cyclin D1的表达及临床意义.癌症. 2006; 25(3):367-372.
doi: 10.3969/j.issn.1000-467X.2006.03.023
[42] Malinowski DP . Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high- grade cervical disease. Biotechniques. 2005
( Suppl):17-23.
[43] Gupta N, Martin PM, Miyauchi S , et al. Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophys Res Commun. 2006; 343(2):571-577.
doi: 10.1016/j.bbrc.2006.02.172 pmid: 16554028
[44] Wu SH, Zhang J, Li Y , et al. Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis. Ai Zheng. 2006; 25(3):315-319. Chinese with abstract in English.
吴素慧, 张静, 李颖 , 等. ETV5对MMP-7在早期宫颈癌组织中的表达及其在转移中的作用.癌症. 2006; 25(3):315-319.
[45] Branca M, Ciotti M, Giorgi C , et al. Matrix metallo- proteinase-2 (MMP-2) and its tissue inhibitor (TIMP- 2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN. Anticancer Res. 2006; 26(2B):1543-1556.
[46] Branca M, Giorgi C, Ciotti M , et al. Down-regulated nucleoside diphosphate kinase nm23_Hl expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J Clin Pathol. 2006; 59(10):1044-1051.
[47] Divya CS, Pillai MR . Antitumor action of curcumin in human papillomavirus associated cells involves downreg- ulation of viral oncogenes, prevention of NF-κB and AP- 1 translocation, and modulation of apoptosis. MolCar- cinog. 2006; 45(5):320-332.
[48] Kim SH, Hwang Cl, Juhnn YS , et al. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis. 2007; 28(1) : 223-231.
doi: 10.1093/carcin/bgl227 pmid: 3222217166886
[49] Putral LN, Bywater MJ, Gu W , et al. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol. 2005; 68(5):1311-1319.
doi: 10.1124/mol.105.014191
[50] Niu XY, Peng ZL, Duan WQ, et al. Inhibition of HPVI6 E6 oncogene in cervical cancer by RNA interference. Sichuan Da Xue Xue Bao ( Yi Xue Ban ). 2006; 37(1):14-18. Chinese with abstract in English.
牛晓宇, 彭芝兰, 段伟强 , 等. RNA干涉抑制宫颈癌 HPV16E6基因的研究. 四川大学学报(医学版). 2006; 37(1):14-18.
[51] Tang S, Tao M , McCoy JP Jr, et al. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene. 2006; 25(14):2094-2104.
doi: 10.1038/sj.onc.1209244
[52] Vogt M, Butz K, Dymalla S , et al. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene. 2006; 25(29):4009-4015.
doi: 10.1038/sj.onc.1209429
[53] Li W, Jian W, Xiaoping X , et al. Enhanced radiation- mediated cell killing of human cervical cancer cells by small interference RNA silencing of ataxia telangiectasia-mutated protein. Int J Gynecol Cancer. 2006; 16(4):1620-1630.
[54] Rossi A, Ciafre S, Balsamo M , et al. Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res. 2006; 66(15) : 7678-7685.
doi: 10.1158/0008-5472.CAN-05-4282
[55] Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-866.
doi: 10.1038/nrc1997 pmid: 17060945
[56] Cho WC . OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007; 6(1) : 60.
doi: 10.1186/1476-4598-6-60
[57] Lui WO, Pourmand N, Patterson BK , et al. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007; 67(13):6031-6043.
doi: 10.1158/0008-5472.CAN-06-0561
[1] Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2] Tara Rajendran, Martha Summa-Chadwick. The scope and potential of music therapy in stroke rehabilitation. Journal of Integrative Medicine, 2022, 20(4): 284-287.
[3] Lu Yin, Yun An, Xiao Chen, Hui-xin Yan, Tao Zhang, Xin-gang Lu, Jun-tao Yan. Local vibration therapy promotes the recovery of nerve function in rats with sciatic nerve injury. Journal of Integrative Medicine, 2022, 20(3): 265-273.
[4] Bin Zhao, Yong Chen, Shi-min Liao, Jian-ying Zheng, Shi-hua Yan, Dong-shu Zhang. Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy: A case report and hypothesized mechanism of the therapy. Journal of Integrative Medicine, 2022, 20(2): 182-186.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[7] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[8] Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.
[9] Zahra Karimzadeh, Mansooreh Azizzadeh Forouzi, Haleh Tajadini, Mehdi Ahmadinejad, Callista Roy, Mahlagha Dehghan. Effects of lavender and Citrus aurantium on pain of conscious intensive care unit patients: A parallel randomized placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(4): 333-339.
[10] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11] Riska Siregar, Aris Setyawan, Syahruramdhani Syahruramdhani. A model to standardize safety and quality of care for cupping therapy. Journal of Integrative Medicine, 2021, 19(4): 327-332.
[12] Bing-rong Li, Shi-yun Shao, Long Yuan, Ru Jia, Jian Sun, Qing Ji, Hua Sui, Li-hong Zhou, Yi Zhang, Hui Liu, Qi Li, Yan Wang, Bi-meng Zhang. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis. Journal of Integrative Medicine, 2021, 19(2): 144-157.
[13] Nurul Afiedia Roslim, Aryati Ahmad, Mardiana Mansor, Myat Moe Thwe Aung, Farrahdilla Hamzah, Haszalina Hassan, Pei Lin Lua. Hypnotherapy for overweight and obese patients: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 1-5.
[14] Johannes Loeser, Brigitte Layer, Christopher Plata, Klaus-Maria Perrar, Tim Hucho, Rebecca Kulbida. Hirudotherapy attenuates arthritic pain in patients with various chronic pain syndromes: A retrospective analysis. Journal of Integrative Medicine, 2020, 18(5): 425-433.
[15] Toktam Sadat Firoozeei, Majid Barekatain, Mehrdad Karimi, Arman Zargaran, Shahin Akhondzadeh, Hossein Rezaeizadeh. Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial. Journal of Integrative Medicine, 2020, 18(5): 409-415.
Viewed
Full text
58
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 1 0 0 57

  From Others local
  Times 0 58
  Rate 0% 100%

Abstract
182
Just accepted Online first Issue
0 0 182
  From Others
  Times 182
  Rate 100%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3